Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Editas Medicine

2.65
-0.1250-4.51%
Volume:1.44M
Turnover:3.85M
Market Cap:404.69M
PE:-3.62
High:2.77
Open:2.77
Low:2.62
Close:2.77
52wk High:4.54
52wk Low:1.66
Shares:153.00M
Float Shares:115.00M
Volume Ratio:1.07
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7307
EPS(LYR):-1.8036
ROE:-118.82%
ROA:-23.29%
PB:3.84
PE(LYR):-1.47

Loading ...

OverviewCompanyNewsFilings

Editas Medicine to present preclinical data for EDIT-401 hyperlipidemia therapy at conferences

Reuters
·
Apr 28

Editas publishes corporate presentation on in vivo gene editing, LDL-C lowering candidate EDIT-401

Reuters
·
Apr 17

Editas Medicine replaces Ernst & Young with PwC as auditor for 2026

Reuters
·
Apr 08

JonesTrading Sticks to Their Buy Rating for Editas Medicine (EDIT)

TIPRANKS
·
Apr 07

USPTO Ruling Impacts Editas Medicine CRISPR IP Position

TIPRANKS
·
Mar 27

Editas Medicine Inc - Uspto Reaffirms Ptab Decision Favoring Broad Institute in CRISPR/Cas9 Patent Interference

THOMSON REUTERS
·
Mar 27

Editas Medicine patent interference narrows; USPTO reaffirms PTAB ruling favoring Broad Institute

Reuters
·
Mar 27

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT)

TIPRANKS
·
Mar 17

Analyst Rate

Buy
Buy
58.33%
Hold
25.00%
Sell
16.67%

Corporate Actions

Financial Report Announcement
Aug 05, 2026 Post-Mkt
Financial Report Announcement
May 05, 2026 Pre-MKt
Financial Report Announcement
Mar 09, 2026 Pre-MKt
Financial Report Announcement
Nov 10, 2025 Pre-MKt
Financial Report Announcement
Aug 12, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-3.79
Current
-3.67
Sector Average
9.06%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-3.79
Maximum
-0.39
+1 STD
0.04
Minimum
-27.03
-1 STD
-7.38
Average
-3.67

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.